cro.directory
← Compare landing

Clinilabs vs Sacura GmbH

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/clinilabs/sacura-cro

CategoryClinilabsSacura GmbH
Listed sitecrocro
SummaryClinilabs is the leading CNS-focused CRO with 25+ years of expertise in neurotherapeutic clinical trials, offering Phase 1–4 trial management, early-phase development, clinical research units, and MedTech device expertise across psychiatry, neurology, substance use, and rare CNS disorders.Sacura specializes in clinical trial management and regulatory support for biotech and pharma companies, with expertise in complex international studies and late-stage preclinical-to-market development planning.
Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Clinical Trial Services
  • Regulatory Affairs
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • CNS Specialty Services
  • Device & Combination Product Services
  • Phase II Clinical Trials
  • Clinical Trial Services
  • EU EMA Regulatory Strategy
  • Clinical Operations
  • Phase I Clinical Trials
  • Phase III Clinical Trials
  • Regulatory Affairs
  • US FDA Regulatory Strategy
ModalitiesData not yet provided.Data not yet provided.
Indications
  • Neurology
  • Psychiatry
  • Rare Disease
Data not yet provided.
Locations
  • Headquarters, Eatontown, New Jersey, United States
  • Regional Office, New York, New York, United States
  • European Headquarters, Allschwil, Basel Area, Switzerland
  • Regional Office, Paris, Île-de-France, France
  • Regional Office, Beijing, Chaoyang District, China
  • Regional Office, Tokyo, Shinjuku-ku, Japan
Data not yet provided.
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.